BCM
EW icon

Brasada Capital Management’s Edwards Lifesciences EW Stock Holding History

Brasada Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-9,186
Closed -$469K – 188
2018
Q4 		$469K Buy
9,186
+9,078
+8,406% +$459K 0.16% 102
2018
Q3 		$6K Buy
+108
New +$5.28K ﹤0.01% 313

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Brasada Capital Management's EW Position: Q1 2019 in Review

Brasada Capital Management sold out of Edwards Lifesciences (EW) in Q1 2019, closing a stake of 9,186 shares — an estimated $469K sold.

Brasada Capital Management first reported a position in EW in Q3 2018 and held it in 2 quarters. The position peaked at $469K in Q4 2018. 922 funds tracked by Wall St. Rank hold EW as of Q1 2019.

  • Brasada Capital Management reported no remaining Edwards Lifesciences position as of Q1 2019 after selling out during the quarter.
  • Brasada Capital Management sold 9,186 Edwards Lifesciences shares in Q1 2019, an estimated $469K.
  • Brasada Capital Management first reported a position in Edwards Lifesciences in Q3 2018 and held it in 2 quarters.
  • Brasada Capital Management's Edwards Lifesciences position peaked at $469K in Q4 2018.
  • 922 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2019.

Based on Brasada Capital Management's 13F filing for Q1 2019, filed 6 May 2019.